| Dr Harvey J Widroe, MD | |
|
37 Quail Court, Suite 200, Walnut Creek, CA 94596 | |
| (925) 944-9711 | |
| (925) 944-9709 |
| Full Name | Dr Harvey J Widroe |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 37 Quail Court, Walnut Creek, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003977851 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SP0808X | Clinical Nurse Specialist - Psychiatric/mental Health | G4880 (California) | Primary |
| 2084P0800X | Psychiatry & Neurology - Psychiatry | G4880 (California) | Primary |
| Entity Name | Comprehensive Psychiatric Services A Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184785834 PECOS PAC ID: 0244329969 Enrollment ID: O20071204000306 |
News Archive
According to a University of Montreal research team, the quality of care provided by female doctors is higher than that of their male counterparts while the productivity of males is greater.
Ancient Egyptian mummies revealed that humans have been hosting parasitic flatworms called schistosomes for more than 5,000 years. Today these parasites continue to plague millions of people across the world, causing roughly 250,000 deaths each year.
BioAtla LLC, a biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics, today announced that it has entered into a license and option agreement with Pfizer Inc. to advance the development and commercialization of a new class of antibody therapeutics based on BioAtla's CAB platform and utilizing Pfizer's proprietary antibody drug conjugate (ADC) payloads.
Weill Cornell Medical College today celebrated the start of construction on its new Medical Research Building, a state-of-the-art facility that will more than double the institution's existing research space. The 18-story, $650 million building is the centerpiece of Weill Cornell's $1.3 billion Discoveries that Make a Difference Campaign, the country's largest for a medical college. A total of $1 billion has been raised toward this goal in a record time of less than four years.
China Aoxing Pharmaceutical Company, Inc. (OTCBB: CAXG) ("China Aoxing"), a China-based pharmaceutical company specializing in research, development, manufacturing and distribution of narcotic and pain-management products, today announced that its Clinical Trial Application ("CTA") for Tilidine/Naloxone Capsules, an opioid drug with abuse resistance property, was officially approved by the China State Food and Drug Administration ("SFDA").
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Harvey J Widroe, MD 37 Quail Court, Suite 200, Walnut Creek, CA 94596 Ph: (925) 944-9711 | Dr Harvey J Widroe, MD 37 Quail Court, Suite 200, Walnut Creek, CA 94596 Ph: (925) 944-9711 |
News Archive
According to a University of Montreal research team, the quality of care provided by female doctors is higher than that of their male counterparts while the productivity of males is greater.
Ancient Egyptian mummies revealed that humans have been hosting parasitic flatworms called schistosomes for more than 5,000 years. Today these parasites continue to plague millions of people across the world, causing roughly 250,000 deaths each year.
BioAtla LLC, a biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics, today announced that it has entered into a license and option agreement with Pfizer Inc. to advance the development and commercialization of a new class of antibody therapeutics based on BioAtla's CAB platform and utilizing Pfizer's proprietary antibody drug conjugate (ADC) payloads.
Weill Cornell Medical College today celebrated the start of construction on its new Medical Research Building, a state-of-the-art facility that will more than double the institution's existing research space. The 18-story, $650 million building is the centerpiece of Weill Cornell's $1.3 billion Discoveries that Make a Difference Campaign, the country's largest for a medical college. A total of $1 billion has been raised toward this goal in a record time of less than four years.
China Aoxing Pharmaceutical Company, Inc. (OTCBB: CAXG) ("China Aoxing"), a China-based pharmaceutical company specializing in research, development, manufacturing and distribution of narcotic and pain-management products, today announced that its Clinical Trial Application ("CTA") for Tilidine/Naloxone Capsules, an opioid drug with abuse resistance property, was officially approved by the China State Food and Drug Administration ("SFDA").
› Verified 9 days ago